Bank of Montreal
ITCI

Bank of Montreal’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bank of Montreal’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,666
Closed -$10.6M – 3808
2025
Q1 		$10.6M Buy
80,666
+16,537
+26% +$2.06M 0.01% 905
2024
Q4 		$5.36M Sell
64,129
-69
-0.1% -$5.67K ﹤0.01% 1185
2024
Q3 		$4.71M Sell
64,198
-228,777
-78% -$17.2M ﹤0.01% 1350
2024
Q2 		$21.2M Sell
292,975
-40,480
-12% -$2.81M 0.01% 747
2024
Q1 		$23.2M Sell
333,455
-1,257
-0.4% -$86.4K 0.01% 685
2023
Q4 		$24.6M Sell
334,712
-119,171
-26% -$6.86M 0.01% 714
2023
Q3 		$26.8M Sell
453,883
-4,470
-1% -$260K 0.01% 618
2023
Q2 		$30.1M Sell
458,353
-3,909
-0.8% -$244K 0.01% 581
2023
Q1 		$26.2M Buy
462,262
+962
+0.2% +$46.5K 0.01% 585
2022
Q4 		$24.7M Sell
461,300
-431
-0.1% -$21.6K 0.01% 622
2022
Q3 		$21.6K Buy
461,731
+1,062
+0.2% +$55.5K 0.01% 660
2022
Q2 		$26.8K Sell
460,669
-6,728
-1% -$381K 0.01% 642
2022
Q1 		$28.3M Buy
467,397
+178,420
+62% +$9.27M 0.01% 663
2021
Q4 		$15.4M Buy
288,977
+273
+0.1% +$11.5K 0.01% 832
2021
Q3 		$10.8M Sell
288,704
-145
-0.1% -$5.04K ﹤0.01% 1246
2021
Q2 		$11.6M Buy
288,849
+65,141
+29% +$2.41M 0.01% 1186
2021
Q1 		$7.05M Buy
223,708
+18,811
+9% +$653K ﹤0.01% 1185
2020
Q4 		$6.56M Buy
204,897
+7,262
+4% +$191K ﹤0.01% 1243
2020
Q3 		$5.11M Buy
197,635
+174,751
+764% +$3.99M ﹤0.01% 1198
2020
Q2 		$559K Buy
22,884
+4,431
+24% +$89.7K ﹤0.01% 2211
2020
Q1 		$266K Buy
18,453
+5,578
+43% +$121K ﹤0.01% 2235
2019
Q4 		$443K Buy
12,875
+6,969
+118% +$83.6K ﹤0.01% 2741
2019
Q3 		$44K Sell
5,906
-1,161
-16% -$11.1K ﹤0.01% 3693
2019
Q2 		$92K Buy
7,067
+3,771
+114% +$48.4K ﹤0.01% 3388
2019
Q1 		$40K Sell
3,296
-2,282
-41% -$29.2K ﹤0.01% 3427
2018
Q4 		$64K Sell
5,578
-55
-1% -$888 ﹤0.01% 3181
2018
Q3 		$122K Sell
5,633
-9
-0.2% -$188 ﹤0.01% 3015
2018
Q2 		$100K Buy
5,642
+318
+6% +$6.46K ﹤0.01% 3121
2018
Q1 		$112K Sell
5,324
-1,000
-16% -$19.5K ﹤0.01% 2908
2017
Q4 		$91K Hold
6,324
– – ﹤0.01% 3040
2017
Q3 		$99K Sell
6,324
-152
-2% -$2.23K ﹤0.01% 2983
2017
Q2 		$80K Sell
6,476
-22,629
-78% -$262K ﹤0.01% 3066
2017
Q1 		$473K Buy
29,105
+25,464
+699% +$369K ﹤0.01% 2122
2016
Q4 		$51K Sell
3,641
-14,531
-80% -$205K ﹤0.01% 3104
2016
Q3 		$278K Buy
18,172
+14,172
+354% +$573K ﹤0.01% 2319
2016
Q2 		$155K Hold
4,000
– – ﹤0.01% 2596
2016
Q1 		$111K Buy
4,000
+3,940
+6,567% +$131K ﹤0.01% 2756
2015
Q4 		$3K Sell
60
-2,940
-98% -$148K ﹤0.01% 3924
2015
Q3 		$120K Buy
+3,000
New +$97.8K ﹤0.01% 2528

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's ITCI Position: Q2 2025 in Review

Bank of Montreal sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 80,666 shares — an estimated $10.6M sold.

Bank of Montreal first reported a position in ITCI in Q3 2015 and held it in 39 quarters. The position peaked at $30.1M in Q2 2023. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Bank of Montreal reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Bank of Montreal sold 80,666 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $10.6M.
  • Bank of Montreal first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 39 quarters.
  • Bank of Montreal's Intra-Cellular Therapies Inc. position peaked at $30.1M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.